KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Net Income (2016 - 2025)

Historic Net Income for BeOne Medicines (ONC) over the last 11 years, with Q3 2025 value amounting to $124.8 million.

  • BeOne Medicines' Net Income rose 20287.68% to $124.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $68.6 million, marking a year-over-year increase of 10796.67%. This contributed to the annual value of -$644.8 million for FY2024, which is 2687.08% up from last year.
  • As of Q3 2025, BeOne Medicines' Net Income stood at $124.8 million, which was up 20287.68% from $94.3 million recorded in Q2 2025.
  • In the past 5 years, BeOne Medicines' Net Income ranged from a high of $215.4 million in Q3 2023 and a low of -$590.7 million during Q4 2021
  • In the last 5 years, BeOne Medicines' Net Income had a median value of -$348.4 million in 2023 and averaged -$250.1 million.
  • In the last 5 years, BeOne Medicines' Net Income plummeted by 75448.23% in 2022 and then soared by 20287.68% in 2025.
  • BeOne Medicines' Net Income (Quarter) stood at -$590.7 million in 2021, then rose by 24.61% to -$445.3 million in 2022, then rose by 17.47% to -$367.6 million in 2023, then soared by 58.68% to -$151.9 million in 2024, then soared by 182.2% to $124.8 million in 2025.
  • Its Net Income was $124.8 million in Q3 2025, compared to $94.3 million in Q2 2025 and $1.3 million in Q1 2025.